About
Dr. David B. Agus is a professor of medicine and engineering at the University of Southern California's Keck School of Medicine and Viterbi School of Engineering. He is the founding director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine of USC. A medical oncologist, Dr. Agus leads a multidisciplinary team of researchers dedicated to the development and use of technologies to guide doctors in making tailored health-care decisions. He is also a co-founder of several personalized medicine companies, including Applied Proteomics, Navigenics, Sensei, and Sensei Agriculture. Dr. Agus is a CBS News contributor and the author of several New York Times and international bestselling books. He serves in leadership roles at the World Economic Forum and the Global Health Security Consortium.
Portfolio
Investment activity
Portfolio by sector
Q&A
- What is Dr David Agus's primary investment focus?
- Dr David Agus has invested in the Health Tech & Life Sciences sector, with one portfolio company in this area.
- Can you name a notable company in Dr David Agus's portfolio?
- A notable company in Dr David Agus's portfolio is Imagene, which operates in the Health Tech & Life Sciences sector.
- What was Dr David Agus's most recent investment activity?
- Dr David Agus participated in an A Round investment in May 2022.
- What is the typical investment stage for Dr David Agus?
- Dr David Agus has participated in an A Round investment.
- What is the typical check size for Dr David Agus?
- Dr David Agus's investment range is between $18.5M and $18.5M.
- How many new portfolio companies did Dr David Agus add in 2022?
- Dr David Agus added one new portfolio company in May 2022.